Financial
Parent RELX (REL.L) group FY2025 revenue £9.59bn (+1.7%); operating margin 31.6%; net income £2.08bn.
Figures cover the whole listed group, not this business alone.
HQ Netherlands · Europe
Directory listing. Financial health and risk summaries come from public sources only (see below); products have not been catalogued yet. Source: HSH editorial list from public company information, November 2026 — awaiting verification.
Parent RELX (REL.L) group FY2025 revenue £9.59bn (+1.7%); operating margin 31.6%; net income £2.08bn.
Figures cover the whole listed group, not this business alone.
Source: official results release · Year ended 2025-12-31 · Band from the latest full-year operating margin in official results: 10% or more Strong, 0–10% Fair, below 0 Weak. Where operating profit is not published, the stated alternative margin is used. Not assessed means no usable public figures.
| Year | Revenue | Growth | Operating profit | Net income | Covers |
|---|---|---|---|---|---|
| FY2025 | £9.6bn | +1.7% | £3bn | £2.1bn | RELX group |
Products not yet catalogued.
Parent RELX (REL.L) group FY2025 revenue £9.59bn (+1.7%); operating margin 31.6%; net income £2.08bn.
Figures cover the whole listed group, not this business alone.
No adverse media involving Elsevier Health found in HSH's search of the last 24 months.
No data breaches or cyber incidents involving Elsevier Health found in HSH's search of the last 24 months. NHS DSPT status not yet checked.
Clinical knowledge and decision-support content supplier; no regulatory or clinical safety actions involving Elsevier Health found in HSH's search of the last 24 months.
Jun 2026: Elsevier announced it had acquired Wellsheet, a tool that brings EHR patient data into clinical workflows, to integrate with ClinicalKey AI. No notable NHS contract news found in HSH's search of the last 24 months.
No competitors linked yet.